Andrew Reikes is an Endocrinology/Metabolic physician affiliated with University of California, Irvine. OpenAlex indexes 15 publications with 1,450 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
35.8%Statin15.9%Atorvastatin Calcium66%Rosuvastatin Calcium23%Pravastatin Sodium6%Simvastatin4%Part D<11 patientsCalcium channel blocker5.5%Amlodipine Besylate100%Part D≥71 patients+ 7 more classes in this area
Metabolism & gastrointestinal
28.9%Biguanide (metformin)6.1%Metformin Hcl56%Metformin Hcl Er44%Part D≥39 patientsGLP-1 receptor agonist6%Rybelsus36%Ozempic30%Trulicity27%Mounjaro7%Part D<11 patients+ 10 more classes in this area
Hormonal (systemic)
15%l-Thyroxine14.5%Levothyroxine Sodium79%Synthroid21%Part D≥117 patientsParathyroid Hormone Analog0.4%Teriparatide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2024 per NIH RePORTER. The latest:
- All of Us Southern California Consortium (AoUSCC): Engagement, Enrollment, and Retention of Diverse Populations
University of California-Irvine
FY2024$4,000,000OT2OD036428 - All of Us Southern California Consortium (AoUSCC): Engagement, Enrollment, and Retention of Diverse Populations
University of California-Irvine
FY2024$300,147OT2OD036428
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- When AI Writes Back: Ethical Considerations by Physicians on AI-Drafted Patient Message Replies
arXiv (Cornell University)
2025 - Insulin Glargine Utilization and Spending Before and After the First Biosimilar Insulin Glargine: A Real-World Data Study
Journal of General Internal Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Susan O’Brien, MD
University of California, Irvine
Steven Potkin, MD
University of California, Irvine
Stefan Ciurea, MD
University of California, Irvine
Farshid Dayyani, MD
University of California, Irvine
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”